2205578909
Investigating human cognition with medically necessary intracranial electrophysiologic recordings
Neurology
16 available clinical trials fall under the “Neurology” category.
2207611017
Assessment of Memory and its Neural Correlates Using Functional Magnetic Resonance Imaging
2210661731
Role of Wearable Devices and Data Analytics in Developing Tools for Early Diagnosis and Prognosis of Movement Disorders
2212689735
WVU RNI Mind and Brain (MiBrain) Registry
2304754574
Development of diagnostic tests for concussion in virtual reality
2308834792
The Feasibility of Wearables Technology in Understanding Memory Disorders
ALXN1720-MG-301
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel, Multicenter Study to Evaluate the Safety and Efficacy of ALXN1720 in Adults with Generalized Myasthenia Gravis
Protocol Number: ALXN1720-MG-301 IND Number: 150823
ASPIRE
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
CAPTIVA
Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis (CAPTIVA)
COMB157GUS10
AGNOS: An 18-month, Open-label, Multi-Center Phase IV Study to Assess the Effect of Ofatumumab 20mg SC Monthly in Treatment Naïve, Very Early Relapsing Remitting Multiple Sclerosis Patients Benchmarked Against Healthy Controls on Select Outcomes
CREST2
Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial (CREST-2)
GN41791
A Phase III Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group
Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab
in Adult Patients with Primary Progressive Multiple Sclerosis
RPC-1063-MS-001
A Multicenter, Longitudinal, Open-Label, Single-Arm Study Describing Cognitive Processing Speed Changes in Relapsing Multiple Sclerosis Subjects Treated with Ozanimod (RPC-1063)
SATURN
STATINS USE IN INTRACEREBRAL HEMORRHAGE PATIENTS
SLEEPSMART
Sleep for Stroke Management And Recovery Trial
WVU02HSC23
A pilot study investigating the correlation between circulating cell-free mitochondria and fatigue in multiple sclerosis patients.